Cathie Wood Eyes Up Psychedelics
LaunchPad is your place to discover, understand, and stay up-to-date with early stage public companies.
Welcome to LaunchPad. Your place to discover, understand, and stay up-to-date with early stage public companies.
ARK's Psychedelic Outlook
ARK Invest, Cathie Wood's management firm with over $14 billion AUM, has released a hyper detailed report on the world of psychedelic medicines, assisted therapies, and their respective commercial outlook in brand new research.
It is one of the most comprehensive looks yet into the potentially massive disruption to traditional pharma and the therapeutic potential of psychedelics to be the next enormous opportunity in biotech.
The Sprint
Patriot Battery Metals (TSXV:PMET) hit a 12-month high after announcing their best lithium drill intercept results to date. Shares of PMET are up over 1,100% in 2022.
BioAffinity Technologies (NASDAQ:BIAF), a lung cancer test developer, raised $7.9M in their IPO and began trading on the Nasdaq.
WonderFi (TSX: WNDR) announced an agreement to acquire Blockchain Foundry, a Canadian company that builds infrastructure for NFTs and crypto assets.
Exro Technologies (TSX: EXRO), a clean technology company based in Calgary, has raised $8.1M CAD in a new financing.
LaunchPad is owned by Bolt Media. To learn more about opportunities to position your brand or company in front of Bolt's 100,000+ community members, reach out here.